These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6678846)

  • 1. Some aspects of the pharmacokinetics of fluorescein in normal and in diabetic subjects.
    Kjaergaard JJ; Dideriksen K; Mourits-Andersen T
    Int J Microcirc Clin Exp; 1983; 2(3):191-7. PubMed ID: 6678846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.
    Kjaergaard JJ; Ohrt V
    Int J Microcirc Clin Exp; 1983; 2(3):207-13. PubMed ID: 6381356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular fluorophotometry in normal subjects.
    Kjaergaard JJ
    Int J Microcirc Clin Exp; 1983; 2(3):199-205. PubMed ID: 6678847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.
    Kaufmann F; Lacoste C
    Diabetologia; 1986 Mar; 29(3):175-80. PubMed ID: 3516774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescein kinetics in perilymph and blood: a fluorophotometric study.
    Applebaum EL
    Laryngoscope; 1982 Jun; 92(6 Pt 1):660-71. PubMed ID: 6806551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein.
    Larsen M; Loft S; Hommel E; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):427-32. PubMed ID: 3195322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.
    Navalesi R; Pilo A; Ferrannini E
    J Clin Invest; 1978 Jan; 61(1):197-208. PubMed ID: 338630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.
    Blair NP; Evans MA; Lesar TS; Willett M
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):114-7. PubMed ID: 2721978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of fluorescein after intravenous administration.
    Chahal PS; Neal MJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):764-8. PubMed ID: 3997424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of fluorescein and carboxyfluorescein by normal and glycosylated human serum proteins.
    Rockey JH; Li W
    Ophthalmic Res; 1982; 14(6):416-27. PubMed ID: 7162770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.
    Welch S; Gebhart SS; Bergman RN; Phillips LS
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1508-18. PubMed ID: 2229309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.
    Taskinen MR; Bogardus C; Kennedy A; Howard BV
    J Clin Invest; 1985 Aug; 76(2):637-44. PubMed ID: 3897287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide.
    Grotte D; Mattox V; Brubaker R
    Exp Eye Res; 1985 Jan; 40(1):23-33. PubMed ID: 3979458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the pharmacokinetics of fluorescein and its dilaurate ester under the conditions of the fluorescein dilaurate test.
    Barry RE; Behrendt WA
    Arzneimittelforschung; 1985; 35(3):644-8. PubMed ID: 4039592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.